Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ACON | Aclarion | $4.78 | -$3.39 | -41.49% | 2.4M | $3.2M | $4.32$1,065.50 |
| AQST | Aquestive Therapeutics | $3.94 | -$2.28 | -36.63% | 1.1M | $477M | $2.12$7.55 |
| BBNX | Beta Bionics | $20.31 | -$11.68 | -36.51% | 319.9K | $887M | $8.89$32.71 |
| ATRA | Atara Biotherapeutics | $13.67 | -$3.77 | -21.62% | 852.3K | $99M | $5.01$19.15 |
| WSHP | WeShop | $65.00 | -$17.00 | -20.73% | 7.7K | $1.5B | $20.02$250.00 |
| NVVE | Nuvve | $3.75 | -$0.96 | -20.38% | 1.6M | $5.0M | $1.98$200.80 |
| SMX | Smx (Security Matters) Public | $23.11 | -$5.05 | -17.93% | 2M | $24M | $3.12$21,304.03 |
| ASPC | A Spac III Acquisition Corp. | $17.75 | -$3.62 | -16.94% | 96.1K | $41M | $9.97$63.98 |
| CDIO | Cardio Diagnostics | $2.05 | -$0.35 | -14.58% | 449.4K | $3.7M | $1.93$21.15 |
| DGNX | Diginex | $3.08 | -$0.48 | -13.48% | 2.7M | $622M | $0.45$39.85 |
Related Articles
Featured Article
2 Steps to Biotech Success: Good Data, Then Raise Capital
Brian Orelli, PhD|Dec 23, 2020
Companies that don't do the second step won't last long in this industry.
![Biotech_Stocks_Step_1_Good_Data,_Step_2_Raise_Capital[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F605702%2Fbiotech_stocks_step_1_good_data_step_2_raise_capital1.jpg&w=384&op=resize)
These 2 Pharma Stocks Could Be Top Stocks in 2020
Amar Khatri|Jul 6, 2020
These pharma stocks are undervalued, and could be solid picks over the long term.
2 Biotech Stocks That Could Soar in 2020
Amar Khatri|Jul 1, 2020
These companies offer promising pipelines that could deliver in the long term.
Advertisement
2 Top Biotech Stocks Under $10
George Budwell, PhD|Apr 27, 2020
Amarin and Atara Biotherapeutics could both be diamonds in the rough.
2 Incredibly Cheap Cancer Stocks to Buy Now
George Budwell, PhD|Jan 30, 2020
These two cancer stocks are trading at a pittance compared to their long-term value propositions.
Where Will Gilead Sciences Spend Its Cash?
George Budwell, PhD|May 7, 2019
Atara Biotherapeutics and Exelixis might be top takeover targets for the biotech giant.
2 Best Biotech Buyout Plays
George Budwell, PhD|Apr 23, 2019
Atara Biotherapeutics and Crispr Therapeutics stand out as strong takeover candidates. Here's why.
Why Delta Air Lines, Atara Biotherapeutics, and Skyworks Solutions Slumped Today
Dan Caplinger|Jan 3, 2019
Find out what made these high-flying stocks lose altitude.
2 High-Flying Biotech Stocks With Even More Room to Grow
George Budwell, PhD|Jun 20, 2018
These two red-hot biotechs are showing no signs of slowing down.
3 Small-Cap Biotech Stocks to Keep on Your Radar
Keith Speights|Jun 20, 2018
Small market caps. Big opportunities.
